SYNOPSIS As a quantitative test of iron storage the six-hour urinary excretion of iron was measured after the intravenous infusion of the iron-chelating agent diethylenetriamine penta-acetic acid (D.T.P.A.). The value of this test in determining the presence and magnitude of the total body iron stores was assessed in patients with diseases of iron storage. In patients with idiopathic haemochromatosis and in their first-degree relatives with increased iron stores as measured by hepatic biopsy, the result of the D.T.P.A. test fell progressively as iron stores were reduced by venesection therapy. There was a significant correlation between the result of the D.T.P.A. test and the excess iron storage as measured retrospectively by the effects of venesection therapy, and also between the D.T.P.A. test and the unsaturated iron-binding capacity (U.I.B.C.) in these patients.
In patients with excess iron stores due to diseases other than idiopathic haemochromatosis (e.g., alcoholic cirrhosis, haemochromatosis associated with refractory anaemia) the D.T.P.A. test demonstrated the presence of excess iron stores, but the results were very variable and did not correlate closely with the U.I.B.C. or the degree of hepatic haemosiderin deposits. Unexpectedly high results for the D.T.P.A. test were found in some patients with iron-deficiency anaemia.
The demonstration that iron-chelating agents promote increased urinary excretion of iron in patients with excess iron stores has led to the use of these agents in the study of iron storage disease. Both diethylenetriamine penta-acetic acid (D.T.P.A.) and desferrioxamine have been used in simple quantitative tests in which the urinary iron excretion following the injection of a known dose of chelating agent is measured at six or 24 hours (Walsh, Perkins, Blackburn, Sanford, and Cantrill, 1963; Keberle, 1964; Lloyd, Powell, and Thomas, 1964; Ploem, de Wael, Verloop, and Punt, 1966; Fielding, O'Shaughnessy, and Brunstrom, 1966) . However, both agents have limitations when used to assess quantitatively the degree of excess storage iron.
Desferrioxamine has more than one metabolic pathway; a variable proportion of the ferrioxamine formed in vivo is used fer haemoglobin synthesis and is not excreted in the urine (Bannerman, Callender, and Williams, 1962) . This can be allowed for if desferrioxamine is injected together with a known dose of ferrioxamine labelled with 59Fe, and Received for publication 21 April 1967. the six-hour excretion of ferrioxamine and 59Fe measured (Fielding, 1965) . Desferrioxamine also chelates iron released from the breakdown of haem in addition to storage iron and thus high chelation values are obtained in haemolytic conditions and in disorders of haem metabolism (Fielding, 1965; O'Shaughnessy, Brunstrom, and Fielding, 1966; Smith, Studley, and Williams, 1967) . D.T.P.A. is a less specific chelating agent for iron than desferrioxamine; small quantities of other cations such as copper, magnesium, lead, and zinc are chelated in addition (Tripod, 1964) . However, the metabolic pathway of D.T.P.A. following intravenous injection appears to be relatively simple. It is distributed widely in the extracellular compartment; 80 to 90 % ofthe administered dose is recovered unchanged in the urine in the first four hours; it does not participate in normal iron exchange between effete red cells, reticuloendothelial cells, and transferrin; and it appears that only tissue iron is chelated (Stevens, Rosoff, Weiner, and Spencer, 1962; Cleton, Turnbull, and Finch, 1963 Walsh et al. (1963) in patients with idiopathic haemochromatosis.
A previous study (Powell, 1966a) has shown that, in rabbits loaded with iron-dextran, the results of a quantitative test using D.T.P.A. correlated with the total body iron excess when the test was performed at a constant time interval after iron loading. The present study was undertaken to assess the value of such a test in determining the presence and magnitude of increased total body iron stores in patients with various diseases of iron storage. An indication of the state of the iron stores in these patients was also obtained by measurement of the serum-iron, total iron-binding capacity (T.I.B.C.), the extent of haemosiderin deposition in hepatic biopsy specimens and bone marrow aspirates, and where possible, by means of repeated venesection.
METHODS
SERUM IRON AND URINARY IRON The serum-iron level was estimated by the method of Trinder (1956) and the total iron-binding capacity (T.I.B.C.) by the method of Ramsay (1957) . Urinary iron was measured by a wetashing technique. To 5 ml. of urine was added 0-2 ml. concentrated sulphuric acid and 0 5 ml. concentrated perchloric acid. During the final stage of digestion 0 1 ml. of hydrogen peroxide (30% w/v) was added and the mixture heated to dryness. After cooling, 2 ml. of water was added and the contents heated to boiling point and again allowed to cool before adding 1 drop of thioglycollic acid and 2-0 ml. of 0-2x%a, x-dipyridyl in buffer (2-0 M sodium acetate/acetic acid, pH 5 0). After mixing and standing for 10 minutes the solutions were read in a spectrophotometer with appropriate standards and blanks which had been treated in the same manner as the test samples. D.T.P.A. TEST (LLOYD et al., 1964 ) The patient's bladder was emptied and the urine discarded. A solution containing 1 g. of D.T.P.A. in 500 ml. of physiological saline was then infused intravenously over exactly one hour. All urine was collected for the six-hour period after the start of the infusion.
Aspiration liver biopsy was performed with a Menghini needle. Tissue was fixed in acid formalin for 48 hours before processing. Sections were stained with haematoxylin and eosin and for free iron by Perls' technique. Iron deposition was graded according to Scheuer, Williams, and Muir (1962) .
CRITERIA FOR VENESECTION Weekly venesections of 500 ml. were performed on those patients with cirrhosis and grade 4 iron deposition in liver biopsy specimens. In each case the presence of excess body iron stores was confirmed by the failure of the haematocrit or haemoglobin concentration to fall by 25 % or more after seven weekly venesections (Haskins, Stevens, Finch, and Finch, 1952; Finch and Barnett, 1957 'T.I.B.C. = total iron-binding capacity "Grading after Scheuer et al. (1962) "Reported in detail elsewhere (Tyrer, Powell, and Burnett, 1966) 'Treatment by venesection, considered complete when patient developed a low haemoglobin concentration, low serum iron level, and high total iron-binding capacity. 'Iron content of major organs of iron storage measured on tissues obtained at necropsy (Tyrer et al., 1966) .
is small the correlation is significant (r = 0984, P < 0-001). In these patients studied serially the response to D.T.P.A. appeared to depend on the degree of unsaturation of the iron-binding capacity of the serum, although the relationship was not a simple linear one (Fig. 3) . Figure 2 demonstrates an observation which was made on three patients when treatment by venesection had been suspended because the serum iron, the haemoglobin concentration, and the result of the D.T.P.A. test had all fallen to subnormal levels. After a further two to three months the serum iron and the result of the D.T.P.A. test had returned to abnormally high levels, and a further 1-5 g. of iron could be removed by venesection before the levels fell again to normal or subnormal values. anaemia, sideroblastic anaemia, and thalassaemia) the serum iron levels were elevated with increased saturation of the T.I.B.C. and there was excess haemosiderin in bone marrow aspirates. In these patients the increase in urinary iron excretion in the D.T.P.A. test (9-6, 9-4, and 4-6 mg. respectively) was similar to that in patients with untreated haemochromatosis although the total iron stores probably varied widely (see discussion).
ALCOHOLIC CIRRHOSIS (TABLE ii) Fourteen patients with alcoholic cirrhosis were studied. In 11 of these stainable iron was present in the liver biopsy but the degree of siderosis (maximum grade 3, mean grade 2) was never as gross as in the cases of haemochromatosis (grade 4). None had been treated by repeated venesection. This group was distinguished from idiopathic haemochromatosis on the basis of the degree of iron excess and by the fact that family studies had failed to reveal excess iron storage in a first-degree relative. In six of these 11 patients the urinary iron excretion in the D.T.P.A. test was increased. However, the mean excretion (0-93 mg.) was much lower than that of patients with haemochromatosis and the D.T.P.A. test did not show the correlation with the degree of hepatic iron deposition which was found in patients with untreated idiopathic haemochromatosis (Powell, 1965) . In the three patients with alcoholic cirrhosis without haemosiderosis the result of the D.T.P.A. test fell within the normal range.
CHRONIC ALCOHOLISM WITHOUT CIRRHOSIS (TABLE II) In all eight patients with chronic alcoholism the D.T.P.A. test was normal. The serum iron level was reduced in two and normal in four others whilst the T.I.B.C. was within the normal range in all six tested. Liver biopsy showed no stainable iron in five, and in the remaining three mild haemosiderosis (grade 1) which is normal (Powell, 1966b Figure 2 . The correlation coefficient between X and log Y is r = --0-927 (P < 0 01). 400 per 100 ml.) concentration. In these six patients studied serially the response to D.T.P.A. showed a significant negative correlation with the degree of unsaturation of the iron-binding capacity although the relationship was not a simple linear one (Fig. 3) . Similar findings were observed with desferrioxamine by Walsh, Mass, Smith, and Lange (1965) . However, this observation may not necessarily mean that the amount of iron chelated by D.T.P.A. is determined by the amount of circulating unsaturated transferrin. Walsh et al. (1963) showed that, in patients with treated haemochromatosis in whom the transferrin had become resaturated, the urinary excretion of iron provoked by D.T.P.A. was only slightly increased. In other words the serum iron was elevated and the T.I.B.C. fully saturated when there was a relatively small excess of body iron. Further increase in iron stores did not alter these values, but was shown by a further increase in urinary iron excretion in the D.T.P.A. test. In our patient A.W. (Fig. 2) , resaturation of transferrin was associated with a substantial increase in response to D.T.P.A. In the present study, the result of the D.T.P.A. test in patients with alcoholic cirrhosis and haemosiderosis showed no constant relation to the serum iron or total iron-binding capacity.
The observation illustrated in Fig. 2 shows that not all storage iron has necessarily been removed by venesection therapy when evidence of iron deficiency appears. During the period in which venesections were withheld the iron absorbed from the gut would probably not have exceeded 5 mg. per day (Haskins et al., 1952) . This is equivalent to 280 mg. over the eight-week period whereas 1,500 mg. was subsequently removed by venesection. It is probable that during this eight-week period the remaining iron, previously non-mobilizable and non-chelatable, was converted to a form which was both chelatable and readily mobilized. In case 12 (Fig. 1) (Powell, 1965; Walsh et al., 1965) and normal or slightly increased amounts (1 0 to 2 5 g.) of iron mobilizable by venesections (Conrad, Berman, and Crosby, 1962; Williams, Williams, Scheuer, Pitcher, Loiseau, and Sherlock, 1967) . Quantitative tests of iron storage using iron-chelating agents can provide useful additional information about the degree of iron excess. The present study has demonstrated a relationship between the urinary iron excretion in the D.T.P.A. test and the amount of storage iron removed subsequently by venesections. Thus, the D.T.P.A. test is of value in the quantitative assessment of excess iron storage in patients with idiopathic haemochromatosis, but liver biopsy is necessary to determine the degree of tissue damage, the presence of cirrhosis, and the distribution of storage iron within the liver.
In patients with diseases of iron storage other than idiopathic haemochromatosis (e.g., alcoholic cirrhosis, secondary haemochromatosis associated with chronic anaemias such as sideroblastic anaemia and thalassaemia) the D.T.P.A. test demonstrated the presence of excess iron stores but the result showed no constant relation to the degree of iron excess as estimated by the serum iron, the T.l.B.C., and liver and marrow haemosiderin deposits. In such conditions the disorder of iron storage is complicated by ineffective erythropoiesis, increased iron absorption, and recent parenteral iron administration, each of which may affect iron chelation. However, as none of these patients was subjected to venesection therapy, firm conclusions cannot be drawn about the relationship between the D.T.P.A. test and body iron stores in these patients.
The results of the D.T.P.A. test in patients with iron deficiency were rather unexpected. Two of the three patients in whom the results were above normal had suffered from gastrointestinal bleeding but it is unlikely that contamination of urine with blood would account for the results obtained. Normal or high levels of urinary iron excretion after the administration of chelating agents have also been found by other workers in iron deficiency (Hwang and Brown, 1964 
